Tags: Hands On Mobile | Harpo Productions | iPhone health apps | mhealth | Oprah Mobile app | Oprah Winfrey | smartphone health apps | US smartphone adoption |
Oprah Winfrey announced the launch of Oprah Mobile this week, a smartphone app that includes content from the talkshow host’s TV and radio shows, O Magazine and affiliated websites. Oprah Mobile is a $1.99 app that offers “helpful advice” on a variety of topics including “spirit, health, beauty, cooking” and more.
As Jason Ankeny writes over at FierceMobileContent, the importance of Oprah Mobile could be tremendous:
“Oprah is unique–more a spiritual leader than a media magnate, her influence on her fanbase is incalculable, and if she tells her audience to download her app, they will listen. For viewers who’ve previously relied on their handsets exclusively to make calls and send text messages, Oprah Mobile could be the application that redefines their user experience.”
What’s more, Oprah Mobile is in part an application that delivers advice for healthy living. The app’s description begins: “Live your best life wherever you go!” That certainly captures the spirit of the opportunity for mHealth services. Keep reading>>
Tags: AllOne Mobile | Diversinet | U.S. Army | wounded warriors |
Diversinet announced its first quarter revenues for 2010 were $576,000, down from $2 million during the same period last year. According to the company, the decrease is largely attributable to AllOne Mobile’s failure to pay its quarterly minimum commitment of $1.75 million per the two companies’ licensing and revenue share agreement inked in late 2008. The two companies are currently moving toward a settlement that would likely terminate the original agreement and see AllOne Mobile paying at least some of the money it owes Diversinet.
Diversinet’s agreement with AllOne Mobile may come to an end as early as next month. Once free from that agreement and with a new product line, Diversinet is poised to capitalize on growing momentum in the mobile health space:
“During the quarter… [Diversinet] introduced a major new release that makes implementing mobile health faster and easier to deploy, along with secure SMS capability that offers broader accessibility,” Diversinet Chairman and CEO Albert Wahbe stated in a company release. ”With our new emphasis on mobile health, we expect to benefit from the strengthening and widespread market demand for the secure mobilisation of health information, driven by both clear economics for healthcare organizations and new U.S. federal legislation providing healthcare IT funding and incentives.” Keep reading>>
Tags: CMS | FDA | Hewlett-Packart | HP buys Palm | Ideal Life | iPhone medical apps | mHealth reimbursement | Miller School of Medicine | Palm |
$1.2B ending to the Palm scuttlebutt: Hewlett-Packard announced plans to acquire Palm for about $1.2 billion in cash. The Wall Street Journal summed the deal up nicely: The deal ends “the scuttlebutt about what would happen to the once-pioneering smartphone maker, [which] has come onto hard times as others have surpassed Palm’s presence in the sector.” Perhaps the medical industry more than others has taken note of Palm’s devices’ fall from grace — just a few years ago Palm’s brand was synonymous with mobile medical applications. We took a quick look at the Palm-HP deal in the context of healthcare enterprise mobility, and found that HP seems to feature healthcare as a key vertical for its (very) limited handheld device offerings already. More
$2 million divided by $400 billion: In other financial news, Senator Ron Wyden (D-Ore) co-chaired a panel on aging in place technologies in the Senate last week. Wyden stated that CMS spent $400 billion in reimbursements last year but only $2 million of it went to eCare services. That’s 0.0005 percent of total reimbursements. Conclusion: Plenty of room for growth in mobile health. More
Crying wolf: While on the government beat, here’s some thoughts about the FDA — consultant and general wireless guru Nick Hunn penned a punchy editorial on the possibility that all this talk about FDA regulation of mHealth might be teetering on the edge of “crying wolf.” It could be scaring some companies away from the mHealth opportunity. Wireless operators, perhaps? More Keep reading>>
Tags: Apple iPad | Marvell | medical tablets | Moby MED platform |
This week MobiHealthNews interviewed Marvell co-founder Weili Dai to discuss the company’s recently announced platform for medical tablets, Moby MED. To clarify other reports about Moby MED, no it is not a tablet — Moby MED is a platform that Marvell’s partners can use to make tablets for medical use cases. In that regard, Moby MED is like Intel’s Mobile Clinical Assistant (MCA) spec, but Marvell’s Dai believes its OEM partners will make tablets for use by consumers looking for a telehealth-centered device, too. Dai said Marvell’s partners will likely unveil the first tablets based on Moby MED at the beginning of 2011. (Expect them in time for the Consumer Electronics Show, which as we noted after attending, is growing its focus on consumer health.)
Dai imagines Moby MED-based tablets could find themselves mounted on the wall in care facilities, in the hands of a clinician or for use at-home by patients conducting video conferencing with their care providers. Dai calls the medical vertical a “tremendous” opportunity. Keep reading>>
Tags: healthcare enterprise mobility | Hewlett Packard | HP buys Palm | Palm | Palm Pre | Palm Pre medical apps |
Hewlett-Packard, which is among other things currently the top seller of PCs in the US and abroad, today announced a $1.2 billion acquisition of Palm. That’s right, the one-time mobile device darling of the healthcare industry may have just gotten another chance at winning back one of its old core user groups: Medical professionals.
In a prepared statement Todd Bradley, executive vice president, Personal Systems Group for HP said: “Palm’s innovative operating system provides an ideal platform to expand HP’s mobility strategy and create a unique HP experience spanning multiple mobile connected devices… The smartphone market is large, profitable and rapidly growing, and companies that can provide an integrated device and experience command a higher share. Advances in mobility are offering significant opportunities, and HP intends to be a leader in this market.”
A careful inspection of HP’s current handheld device offerings for the enterprise yield the HP iPAQ Pocket PC smartphone and PDA. Of the nine case studies profiled by HP for the iPAQ devices, three of them explain how an iPAQ device has impacted the healthcare industry. A medical student is profiled for his use of Epocrates Essentials on his iPAQ, a pharmaceutical sales staff’s iPAQ usage is chronicled and a care provider facility explains how its clinicians use iPAQs to access the organization’s electronic medical records remotely. While it’s not a precise way to gauge HP’s commitment to mobility solutions for the healthcare industry, it’s clear that the healthcare vertical is a dominant one for HP’s current mobile offering. Keep reading>>
Tags: FDA | mHealth regulation | smartphone medical apps | smartphones |
By Nick Hunn
Everyone seems to think that mHealth is about to take off. MobiHealthNews’s recent roundup of analyst predictions estimated sales of around $4 billion per year by 2014, and my own more fanciful review of potential savings ran into tens of billions of dollars. Network operators are setting up mHealth divisions faster than you can say “long term chronic condition” and the outpouring of mHealth apps for smartphones continues to grow exponentially.
It has all of the characteristics of the next technical bubble, but with the added benefit that, if we can make it work, it might actually save our healthcare systems from terminal meltdown. We need the disruption that mHealth will bring. As Clayton Christensen points out in his seminal book – The Innovator’s Prescription, the only way we are going to effect a major change in healthcare is through the introduction of new, parallel business models to challenge those that our current healthcare structure is built on. That will need new technologies that provide more effective diagnosis of symptoms, as well as devices that encourage personal participation in healthcare by putting monitoring and health records into the hands of patients. Which are exactly the areas being targeted by the mHealth community.
However, there’s an invisible gorilla in the mHealth room that could consign the whole enterprise to history. It’s called the FDA. The FDA has the ability to apply regulations that would choke the development of mHealth. Like all regulators, the FDA moves slowly – far more slowly than the emerging mHealth technology. It is important for the industry to engage with it to reset the levels of regulation for mHealth. What is worrying is that most of the noise around regulation is not about that resetting of expectations, but scare-mongering about the possible reaction of the FDA to an expansion of connected healthcare and new delivery methods. It’s important that manufacturers understand the barriers that regulation might bring, but we’re at risk of crying “Wolf” to the extent that mHealth may never happen, or else only evolve outside the U.S. Keep reading>>